Back

Complementing results from randomised trials: the value of international observational studies.

26 August 2018 (13:35 - 13:50)
Organised by:
Congress Presentation Part of: Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail
Introduction - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice.
Doctor J. Weitz (Hamilton, CA)
Presentation thumbnail
Safety of non-vitamin K antagonist oral anticoagulants - Considerations for management of atrial fibrillation patients .
Doctor C. Ruff (Boston, US)
Presentation thumbnail
Implication of the new EHRA practical guide for the treatment of atrial fibrillation patients.
Professor J. Steffel (Zurich, CH)
Presentation thumbnail
Panel discussion - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice
Doctor J. Weitz (Hamilton, CA)
Presentation thumbnail
Summary and close - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice.
Professor P. Kirchhof (Hamburg, DE)

Access the full session

Session thumbnail
Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice

The Event

Event poster

ESC Congress 2018

26 August 2018 13:35 CET
You may be interested in
thumbnail
Congress Presentation
The power of data in hypertension
31 August 2024
thumbnail
Congress Presentation
The influence of concomitant antiplatelet therapy in venous thromboembolism patients treated with anticoagulants in the DOAC era: insight from the COMMAND VTE Registry-2
1 September 2024
thumbnail
Congress Presentation
Comparative outcomes between empagliflozin and dapagliflozin in heart failure: real world multi-center cohort study
31 August 2024
thumbnail
Congress Presentation
Risks and benefits of antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease: a nationwide cohort study
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources